Prostate MRI at Windsong helps urologists and oncologists better visualize suspected prostate cancer using MRI technology. Windsong was the first to offer 3T Prostate MRI in the Western New York region and is one of only a few standalone imaging facilities in Upstate New York that offer this comprehensive solution. This exam is especially helpful for those patients that have had negative TRUS (trans rectal ultrasound) biopsies, and have elevated and/or rising PSA levels. We welcome our Canadian patients from across the border to experience this new technique which incorporates the high resolution of Windsong’s 3T MRI, which provides the ability to offer increased sensitivity and an improved accuracy in localizing prostate cancer.
The typical male patient may have been to his primary care provider, who has been watching an elevating PSA level, and has decided to refer the patient to a urologist. The urologist will often then perform the blind ultrasound-guided TRUS procedure, where up to 14 core samples from the gland are taken. They are sent to a pathologist, and the results may come back negative. The patient and his doctors will then go through the ‘watchful waiting’ period until the next PSA level is taken. If the next PSA level is still elevated and rising, then another TRUS biopsy could be performed.
With Windsong’s prostate 3T MRI the patient now has an alternative that provides a more targeted approach. “Prostate MRI has revolutionized how we diagnose prostate cancer. It enables us to find disease earlier than today’s conventional tests.” according to Raja Cheruvu, MD, Windsong radiologist. For more information call or to schedule an appointment call 716.631.2500.
- Location for the Prostate MRI
- Diagnostic CAD [55 Spindrift Drive, Williamsville, NY]
- MR guided prostate biopsy [55 Spindrift Drive, Williamsville, NY]
Indications for Diagnostic Prostate MRI
- Patients with an elevated PSA (Prostate Specific Antigen) level > 4 or abnormally high PSA
- Negative prior TRUS (Trans Rectal Ultra Sound) guided biopsy with continued elevation or rising PSA.
- Positive DRE with negative TRUS-guided biopsy
- Preoperative/treatment planning
- Active surveillance after prostectomy, radiation, or hormonal therapy for prostate cancer.